Human K + channel and prognosing applications thereof

Details Human K + channel and prognosing applications thereof Human K + channel and prognosing applications thereof

2008-04-29

2008-04-29

O'Hara, Eileen (Department: 1647)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

10188296

ABSTRACT:
The present invention relates to a novel human K+ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention. The invention also envisages specific antisense or gene therapies on the basis of the nucleic acid molecule of the invention for inhibiting undesired cellular proliferation, for example, in connection with cancer or in neurodegenerative diseases.

REFERENCES:
patent: WO 92/11034 (1992-07-01), None
patent: WO 94/18961 (1994-09-01), None
Pardo, L., 2004, Physiol. 19: 285-292.
Pardo, et al, 1999, EMBO J., 18(20): 5540-5547.
Farias, et al, 2004, Cancer Res., 64: 6996-7001.
Finch PW, Murphy F, Cardinale I, Krueger JG, 1997, Altered expression of keratinocyte growth factor and its receptor in psoriasis, Am J Pathol. 151(6): 1619-1628.
J. Ludwig, et al., “Functional expression of a rat homologue of the voltage gatedether a go-gopotassium channel reveals differences in selectivity and activation kinetics between theDrosophilachannel and its mammalian counterpart,”The EMBO Journal, 13(19), pp. 4451-4458 (1994).
T. Occhiodoro, et al., “Cloning of a humanether-a-go-gopotassium channel expressed in myoblasts at the onset of fusion,”FEBS Letters, 434, pp. 177-182 (1998).
H. Suessbrich, et al., “Blockade of HERG channels expressed inXenopusoocytes by the histamine receptor antagonists terfenadine and astemizole,”FEBS Letters, 385, pp. 77-80 (1996).
M.C. Trudeau, et al., “HERG, a human inward rectifier in the voltage-gated potassium channel family,”Science, 269, pp. 92-95 (1995).
J.W. Warmke, et al., “A family of potassium channel genes related toeaginDrosophilaand mammals,”Proc. Natl. Acad. Sci. USA, 91, pp. 3438-3442 (1994).
Arendt, Disturbance of neuronal plasticity is a critical pathogenic event in Alzheimer's disease,International Journal of Developmental Neuroscience, 19:231-245 (2001).
Compston, “Brain Repair,”Journal of Internal Medicine, 237:127-134 (1995).
Das, “Estorgen, Statins, and Polyunsaturated Fatty Acids: Similarities in Their Actions and Benefits—Is There a Common Link?,”Nutrition, 18:178-188 (2002).
Gagnon et al., “Gangliosides: therapeutic agents or therapeutic targets?,”Expert Opinions in Ther. Patents, 12(8):1215-1223 (2002).
Lüth et al., “Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21rasand p16INK4a,”Brain Research, 852:45-55 (2000).
Meyer et al., “Characterization of an eag-like potassium channel in human neuroblastoma cells,”Journal of Physiology, 508:49-56 (1998).
Monaco et al., “Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians,”Current Medicinal Chemistry, 10:367-379 (2003).
Nguyen et al., “Cycling at the interface between neurodevelopment and neurodegeneration,”Cell Death and Differentiation, 9:1294-1306 (2002).
Finch et al., “Altered Expression of Keratinocyte Growth Factor and Its Receptor in Psoriasis,”American Journal of Pathology, 151(6):1619-1628 (1997).

Affiliated with

Also associated with

Rating

Human K + channel and prognosing applications thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human K + channel and prognosing applications thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human K + channel and prognosing applications thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3942666